Not Signed In - News
1 - 4 of 4
- Alfacell Updates Progress On Clinical Development Program For ONCONASE(R) In Malignant Mesothelioma
MedicalNewsToday - Fri, 01 Sep 2006 07:00 EST
- Alfacell Corporation Announces New Research Collaboration To Develop Next-Generation Targeted Therapies For Cancer
MedicalNewsToday - Wed, 12 Jul 2006 06:00 EST
- Alfacell Provides Update On The ONCONASE Phase IIIb Registration Trial
MedicalNewsToday - Fri, 23 Jun 2006 06:00 EST
- New OnconaSE(R) Non-Small Cell Lung Cancer Data
MedicalNewsToday - Sat, 13 May 2006 06:00 EST
Clinical Trials
1 - 1 of 1
- ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
ClinicalTrials.gov Identifier: NCT00003034 - Active, not recruiting
localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
email this page
print this page
bookmark this page
feedback on this page
